Campbell & CO Investment Adviser LLC Seagen Inc. Transaction History

Campbell & CO Investment Adviser LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $949,992 - $1.13 Million	-8,094 Reduced 75.52%	2,623 $337,000
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $1.26 Million - $1.67 Million	9,295 Added 653.66%	10,717 $1.47 Million
Q2 2022 Aug 09, 2022	BUY	$108.81 - $179.33 $154,727 - $255,007	1,422 New	1,422 $252,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.